vs

Side-by-side financial comparison of ASTRONICS CORP (ATRO) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $240.1M, roughly 1.1× ASTRONICS CORP). On growth, ASTRONICS CORP posted the faster year-over-year revenue change (15.1% vs -16.5%). ASTRONICS CORP produced more free cash flow last quarter ($15.8M vs $3.4M).

Astronics Corporation is an American aerospace electronics corporation founded in 1968, headquartered in East Aurora, New York. It is traded on NASDAQ as Nasdaq: ATRO. It is known for lighting and electronics integrations on military, commercial, and business aircraft and semiconductor test systems.

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

ATRO vs HCM — Head-to-Head

Bigger by revenue
HCM
HCM
1.1× larger
HCM
$270.8M
$240.1M
ATRO
Growing faster (revenue YoY)
ATRO
ATRO
+31.7% gap
ATRO
15.1%
-16.5%
HCM
More free cash flow
ATRO
ATRO
$12.5M more FCF
ATRO
$15.8M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ATRO
ATRO
HCM
HCM
Revenue
$240.1M
$270.8M
Net Profit
$2.0M
Gross Margin
33.3%
37.7%
Operating Margin
14.8%
-13.2%
Net Margin
0.7%
Revenue YoY
15.1%
-16.5%
Net Profit YoY
-83.6%
EPS (diluted)
$0.82
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATRO
ATRO
HCM
HCM
Q4 25
$240.1M
$270.8M
Q3 25
$211.4M
Q2 25
$204.7M
$277.7M
Q1 25
$205.9M
$324.5M
Q4 24
$208.5M
Q3 24
$203.7M
Q2 24
$198.1M
$305.7M
Q1 24
$185.1M
Net Profit
ATRO
ATRO
HCM
HCM
Q4 25
$2.0M
Q3 25
$-11.1M
Q2 25
$1.3M
$455.0M
Q1 25
$9.5M
$11.9M
Q4 24
Q3 24
$-11.7M
Q2 24
$1.5M
$25.8M
Q1 24
$-3.2M
Gross Margin
ATRO
ATRO
HCM
HCM
Q4 25
33.3%
37.7%
Q3 25
30.5%
Q2 25
25.8%
0.1%
Q1 25
29.5%
48.0%
Q4 24
29.8%
Q3 24
27.1%
Q2 24
28.0%
41.1%
Q1 24
25.7%
Operating Margin
ATRO
ATRO
HCM
HCM
Q4 25
14.8%
-13.2%
Q3 25
10.9%
Q2 25
2.3%
-1.3%
Q1 25
6.4%
-5.0%
Q4 24
4.3%
Q3 24
4.1%
Q2 24
3.8%
-9.0%
Q1 24
0.9%
Net Margin
ATRO
ATRO
HCM
HCM
Q4 25
0.7%
Q3 25
-5.2%
Q2 25
0.6%
163.8%
Q1 25
4.6%
3.7%
Q4 24
Q3 24
-5.8%
Q2 24
0.8%
8.4%
Q1 24
-1.7%
EPS (diluted)
ATRO
ATRO
HCM
HCM
Q4 25
$0.82
$0.00
Q3 25
$-0.31
Q2 25
$0.04
$0.52
Q1 25
$0.26
$0.01
Q4 24
$-0.07
Q3 24
$-0.34
Q2 24
$0.04
$0.03
Q1 24
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATRO
ATRO
HCM
HCM
Cash + ST InvestmentsLiquidity on hand
$18.2M
$1.4B
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$140.1M
$1.2B
Total Assets
$706.7M
$1.8B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATRO
ATRO
HCM
HCM
Q4 25
$18.2M
$1.4B
Q3 25
$13.5M
Q2 25
$13.5M
$1.4B
Q1 25
$24.8M
$836.1M
Q4 24
$9.3M
Q3 24
$5.2M
Q2 24
$2.9M
$802.5M
Q1 24
$5.3M
Total Debt
ATRO
ATRO
HCM
HCM
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Q1 24
Stockholders' Equity
ATRO
ATRO
HCM
HCM
Q4 25
$140.1M
$1.2B
Q3 25
$108.9M
Q2 25
$271.6M
$1.2B
Q1 25
$266.8M
$759.9M
Q4 24
$256.1M
Q3 24
$249.2M
Q2 24
$257.9M
$740.1M
Q1 24
$251.7M
Total Assets
ATRO
ATRO
HCM
HCM
Q4 25
$706.7M
$1.8B
Q3 25
$682.2M
Q2 25
$646.7M
$1.8B
Q1 25
$662.2M
$1.3B
Q4 24
$648.8M
Q3 24
$651.6M
Q2 24
$644.9M
$1.3B
Q1 24
$630.0M
Debt / Equity
ATRO
ATRO
HCM
HCM
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATRO
ATRO
HCM
HCM
Operating Cash FlowLast quarter
$27.6M
$8.2M
Free Cash FlowOCF − Capex
$15.8M
$3.4M
FCF MarginFCF / Revenue
6.6%
1.2%
Capex IntensityCapex / Revenue
4.9%
1.8%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$43.1M
$-96.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATRO
ATRO
HCM
HCM
Q4 25
$27.6M
$8.2M
Q3 25
$34.2M
Q2 25
$-7.6M
$-72.9M
Q1 25
$20.6M
$40.3M
Q4 24
$26.4M
Q3 24
$8.4M
Q2 24
$-6.3M
$-39.8M
Q1 24
$2.0M
Free Cash Flow
ATRO
ATRO
HCM
HCM
Q4 25
$15.8M
$3.4M
Q3 25
$21.0M
Q2 25
$-12.2M
$-82.2M
Q1 25
$18.5M
$32.5M
Q4 24
$23.2M
Q3 24
$6.5M
Q2 24
$-8.1M
$-49.9M
Q1 24
$439.0K
FCF Margin
ATRO
ATRO
HCM
HCM
Q4 25
6.6%
1.2%
Q3 25
9.9%
Q2 25
-6.0%
-29.6%
Q1 25
9.0%
10.0%
Q4 24
11.1%
Q3 24
3.2%
Q2 24
-4.1%
-16.3%
Q1 24
0.2%
Capex Intensity
ATRO
ATRO
HCM
HCM
Q4 25
4.9%
1.8%
Q3 25
6.2%
Q2 25
2.2%
3.3%
Q1 25
1.0%
2.4%
Q4 24
1.5%
Q3 24
0.9%
Q2 24
0.9%
3.3%
Q1 24
0.9%
Cash Conversion
ATRO
ATRO
HCM
HCM
Q4 25
4.21×
Q3 25
Q2 25
-5.81×
-0.16×
Q1 25
2.17×
3.38×
Q4 24
Q3 24
Q2 24
-4.08×
-1.54×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATRO
ATRO

Product Line Electrical Power And Motion$113.8M47%
Product Line Avionics$32.0M13%
Military Aircraft$28.0M12%
General Aviation$22.3M9%
Government And Defense$20.5M9%
Product Line Systems Certification$13.2M6%
Product Line Structures$3.7M2%
Product Line Other$2.3M1%

HCM
HCM

Segment breakdown not available.

Related Comparisons